Tag Archives: Turing Pharmaceuticals

“A sweetheart deal” “deplorable” “immoral and unacceptable” “Massive victory for big pharma” . . . We’re reading about TPP’s pharma rules, and an update on a 5000-percent price hike

By on .

(Spoiler alert: The price of a life-saving treatment for toxoplasmosis remains unchanged, a month after company CEO Martin Shkreli said it would drop . . . )  But first: The world got glimpse of what the Trans Pacific Partnership offers pharmaceutical companies last week with the WikiLeaks release of the treaty’s Intellectual Property Rights chapter, a […]

Drug price hikes get attention and an “unheralded hero” is remembered . . . We’re reading about profits and purpose

By on .

The two medicines that made the news this week were not widely known, but are potential lifesavers for the people to whom they are prescribed. Pyrimethamine, sold as Daraprim, is a critical treatment for toxoplasmosis, a parasitic infection that is life-threatening for patients with compromised immune systems, including people with HIV. Cycloserine is used to treat […]